As a cell adjuvant with artificial CTA suppressed the generation of exhausted CD8+ T cells and induced memory-like T cells (Fig. 2), we investigated whether the endogenous CTA had a similar effect on CD8+ T cell phenotypes and whether such phenotypic changes altered tumor unresponsiveness to the PD-1 blockade therapy. The gene discussed is CD8A; the disease is neoplasm.